UCL Business

About The Fund

UCL Business, also known as UCLB, is a prominent technology development and commercialization company affiliated with University College London (UCL). Founded in 1993 and stationed in London, U.K., their primary function is to facilitate the transfer of UCL’s cutting-edge research outputs to the commercial sphere, ensuring impactful real-world applications. UCLB operates the UCL Technology Fund, which specializes in investing in intellectual property commercialization opportunities, particularly originating from UCL's extensive research in the physical and life sciences sectors. They are dedicated to supporting the advancement of innovations that hold the potential to address complex and pressing global issues. With an investment minimum and maximum of £2,150,000, they engage with a broad range of stakeholders, including UCL's renowned academics, faculties, and associated hospitals. Their portfolio highlights a commitment to the life-changing technologies that span therapeutics, diagnostics, and social ventures, among others. UCLB champions the progression from concept to market by providing support in protecting intellectual property, advancing research through partnerships, creating spinouts, and licensing technologies via platforms such as XIP and e-lucid. The company has a robust clinical-stage therapeutic pipeline and actively participates in elevating social ventures. Furthermore, UCLB serves as a hub of resources for UCL researchers and NHS staff, including material transfer agreements and non-disclosure agreements. They cultivate an entrepreneurial ecosystem, offering services like project management support, hosting events, and disseminating news related to their ventures and breakthroughs. The strategic cooperation with various entities exemplifies UCLB's dedication to fostering innovation for a better world through the commercial success of UCL's intellectual assets.